EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Accepting to Participate in an Early‐Phase Clinical Trial in Oncology: A Qualitative Study on the Patients' Experiences, Understanding, and Inner Motivations

Estelle Guerdoux iD, Anne Stoebner iD, Louise Coutant iD, Marion Zamith-Chavant, Sylvie Dolbeault iD, Jessica Martinez iD, Marta Jarlier iD, Diego Tosi iD

Psycho-Oncology · 2025

DOI: 10.1002/pon.70291 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Estelle Guerdoux und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative and Supportive Care, Montpellier Cancer Institute, University of Montpellier, Montpellier, France. Hauptthemen laut MEDLINE: Neoplasms, Patient Participation, Motivation, Clinical Trials as Topic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SIRIC Montpellier Cancer, GEFLUC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical trial landscape in oncology has evolved, with shifting endpoints and increased emphasis on early‐phase clinical trials (EPCTs) across European centers.

Aims

This study aimed to update knowledge on the experiences of patients enrolling in EPCTs, focusing on the individual/contextual factors influencing decision‐making, and how to improve ethical and psycho‐oncological support.

Methods

This qualitative single‐center study was part of a broader multicenter project. Twenty‐five patients with locally advanced or metastatic solid cancer, for whom standard therapies had failed, were interviewed face‐to‐face, at a French EPCT center. A reflexive thematic analysis of the transcripts was conducted, following Braun and Clarke's six‐step approach.

Results

Four overarching themes emerged: “Experiencing the EPCT proposal”, “Accepting the EPCT”, “Ambivalent feelings” and “Coping strategies”, and several subthemes. Decisions were often made quickly in crisis situations and perceived as the only option. While patients reported receiving adequate information, their understanding of the trial's aims varied. Emotional distress and time pressure likely hindered full comprehension. Patients relied on trust in clinicians and reframed trial participation as a constructive goal, drawing on coping strategies to manage uncertainty and restore a sense of coherence.

Conclusions

Patients were neither delusional nor misinformed, but their decisions were shaped by complex emotional and relational dynamics. The perception of being well informed does not ensure true understanding, especially in high‐stress contexts. Ambivalent emotions, tensions between expectations and hopes, and constrained choices should be considered when tailoring supportive care. Evidence‐based strategies are needed to enhance communication and shared decision‐making in EPCT settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsPatient ParticipationMotivationClinical Trials as TopicHumansQualitative ResearchFemaleMaleMiddle AgedAgedDecision MakingAdultAdaptation, PsychologicalComprehensionAged, 80 and over

Stichwörter der Autor:innen

acceptationcancerclinical trialcopingdecision‐makingearly‐phaseenrollmentexperiencemotivationqualitative

Autor:innen und Institutionen

  • Department of Palliative and Supportive Care, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
  • Desbrest Institute of Epidemiology and Public Health, INSERM, University of Montpellier, Montpellier, France.
  • Department of Supportive Care, Toulouse Cancer University Institute - Oncopole, Toulouse, France.
  • Department of Supportive Care, Curie Institute, Paris, France.
  • SHARE, PSL University, Paris, France.
  • Department of Medical Oncology, Early Clinical Trial Unit, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.

ORCID-Profile: Estelle Guerdoux, Anne Stoebner, Louise Coutant, Sylvie Dolbeault, Jessica Martinez, Marta Jarlier, Diego Tosi

Förderung

  • SIRIC Montpellier Cancer
  • GEFLUC

Zitieren

APA

Guerdoux, E., Stoebner, A., Coutant, L., Zamith-Chavant, M., Dolbeault, S., Martinez, J., Jarlier, M., & Tosi, D. (2025). Accepting to Participate in an Early‐Phase Clinical Trial in Oncology: A Qualitative Study on the Patients' Experiences, Understanding, and Inner Motivations. Psycho-Oncology. https://doi.org/10.1002/pon.70291

Vancouver

Guerdoux E, Stoebner A, Coutant L, Zamith-Chavant M, Dolbeault S, Martinez J, et al. Accepting to Participate in an Early‐Phase Clinical Trial in Oncology: A Qualitative Study on the Patients' Experiences, Understanding, and Inner Motivations. Psycho-Oncology. 2025. doi:10.1002/pon.70291

BibTeX
@article{Guerdoux2025,
  author = {Guerdoux, Estelle and Stoebner, Anne and Coutant, Louise and Zamith-Chavant, Marion and Dolbeault, Sylvie and Martinez, Jessica and Jarlier, Marta and Tosi, Diego},
  title = {Accepting to Participate in an Early‐Phase Clinical Trial in Oncology: A Qualitative Study on the Patients' Experiences, Understanding, and Inner Motivations},
  journal = {Psycho-Oncology},
  year = {2025},
  doi = {10.1002/pon.70291}
}
Kostenlos starten →